Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Commentary on "prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: Mortality results after 13 years of follow-up". Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; PLCO Project Team.Collaborators (18) Buring JE, Alberts D, Carter HB, Chodak G, Hawk E, Malm H, Mayer RJ, Piantadosi S, Silvestri GA, Thompson IM, Westhoff CL, Kahn JP, Levin B, DeMets D, O'Fallon JR, Porter AT, Ashton MM, Black WC, Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO 63130, USA: J. Natl Cancer Inst 2012; 104(2):125-32. Epub January 6, 2012.

× No keyword cloud information.

14 in total

1. Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal.

Authors: Bradley D Anawalt
Journal: J Clin Endocrinol Metab Date: 2010-06 Impact factor: 5.958

2. Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion.

Authors: Robert K Nam; Thomas K Oliver; Andrew J Vickers; Ian Thompson; Philip W Kantoff; Howard L Parnes; Andrew Loblaw; Bruce J Roth; Jim Williams; Sarah Temin; Ethan Basch
Journal: J Oncol Pract Date: 2012-09 Impact factor: 3.840

3. Screening for prostate cancer in the US? Reduce the harms and keep the benefit.

Authors: Tiago M de Carvalho; Eveline A M Heijnsdijk; Harry J de Koning
Journal: Int J Cancer Date: 2014-09-01 Impact factor: 7.396

4. Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition of the EDIFICE Survey.

Authors: Jérôme Viguier; Jean-François Morère; Xavier Pivot; Chantal Touboul; Christine Lhomel; Sébastien Couraud; Thibault de La Motte Rouge; François Eisinger
Journal: Curr Oncol Rep Date: 2018-03-05 Impact factor: 5.075

5. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.

Authors: Jeannette T Bensen; Zongli Xu; Gary J Smith; James L Mohler; Elizabeth T H Fontham; Jack A Taylor
Journal: Prostate Date: 2012-05-01 Impact factor: 4.104

6. Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Authors: Roman Gulati; John L Gore; Ruth Etzioni
Journal: Ann Intern Med Date: 2013-02-05 Impact factor: 25.391

7. Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial.

Authors: Paul F Pinsky; Eric Miller; Philip Prorok; Robert Grubb; E David Crawford; Gerald Andriole
Journal: BJU Int Date: 2018-11-02 Impact factor: 5.588

8. Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Authors: Paul F Pinsky; Amanda Black; Howard L Parnes; Robert Grubb; E David Crawford; Anthony Miller; Douglas Reding; Gerald Andriole
Journal: Cancer Epidemiol Date: 2012-09-19 Impact factor: 2.984

Review 9. What do the screening trials really tell us and where do we go from here?

Authors: Ruth D Etzioni; Ian M Thompson
Journal: Urol Clin North Am Date: 2014-02-19 Impact factor: 2.241

10. Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening.

Authors: Ruth Etzioni; Roman Gulati; Matt R Cooperberg; David M Penson; Noel S Weiss; Ian M Thompson
Journal: Med Care Date: 2013-04 Impact factor: 2.983